Skip to main content
. Author manuscript; available in PMC: 2022 Feb 24.
Published in final edited form as: Neuron. 2020 Apr 9;106(6):952–962.e5. doi: 10.1016/j.neuron.2020.03.012

Figure 5. Congenital myasthenic syndrome mutations in the receptor.

Figure 5.

Amino acids identified in human fast- or slow-channel syndromes are shown as spheres mapped onto the Torpedo structure. Point mutations in the human muscle nicotinic receptor causing myasthenia are found predominantly on α1 and ε subunits. The majority of the residues at these positions are conserved in the Torpedo receptor α and γ subunits, respectively (α1/α: 80% and ε/γ: 56% amino acid sequence identity).